• About
  • Services
  • News and Updates
  • Careers
  • Contact
  • Locations
    • LinkedIn
3PBIOVIAN
  • Proteins
    • Microbial Proteins
    • Mammalian Proteins
  • Viral Vectors
    • AAV Manufacturing
    • Adenovirus Manufacturing
    • AAVion® Platform
  • Plasmid DNA
  • Cell Therapies
  • Other Services
    • Aseptic Fill & Finish
    • QC Services
    • Conjugated Biotherapeutics

3PBiovian Team

BIO International 2025

February 6, 2025

Read more >

Festival of Biologics

February 6, 2025

Read more >

Advanced Therapies UK

February 6, 2025

Read more >

BIO-Europe Spring

February 6, 2025

Read more >
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline

Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline

February 4, 2025

Read more >
3PBIOVIAN, is pleased to announce the appointment of Almira Bartolomé as Business Development Director for Advanced Therapies

3PBIOVIAN strengthens its Leadership team with the appointment of a Business Development Director for Advanced Therapies

October 9, 2024

Read more >
3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston // 3BIOVIAN / Affinity in the making

3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston

September 25, 2024

Read more >

3PBIOVIAN strengthens its executive team with the appointment of three new directors

September 19, 2024

Read more >
Rokote Laboratories Finland Ltd. has selected 3PBIOVIAN as their CDMO partner for GMP manufacturing of adenovirus type 5 (Ad5) vector-based candidate expressing a modified spike protein of severe acute respiratory coronavirus 2 (SARS-CoV-2).

Rokote Laboratories signs an agreement with 3PBIOVIAN for GMP manufacturing of adenovirus vector-based COVID-19 vaccine

August 29, 2024

Read more >

Bio Europe Fall

June 20, 2024

Read more >

Festival of Biologics Europe

June 20, 2024

Read more >

CPHI

June 20, 2024

Read more >

BioProcess International

June 20, 2024

Read more >

Bioprocessing Summit Boston

June 20, 2024

Read more >

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO

February 1, 2024

Read more >

BIO International 2024

January 15, 2024

Read more >
« Previous 1 2 3 4 5 … 7 Next »

Say hello.

Passionate about progress and people, we work in harmony with our partners, always close, all the way.

"*" indicates required fields

By submitting this form, 3P BIOPHARMACEUTICALS, S.L.U. will use the personal data you provide us with to send you the requested information. It is hereby informed that the services of this website are intended for adults (individuals who have reached the legal age). You may withdraw your consent at any time by notifying us at complianceofficer@3pbio.com. Such withdrawal will not affect the lawfulness of any processing based on consent given prior to its withdrawal.

Consent Privacy Policy*
Consent Newsletter*

Services

  • Proteins
    • Microbial Proteins
    • Mammalian Proteins
  • Viral Vectors
    • AAV Manufacturing
    • Adenovirus Manufacturing
    • AAVion® Platform
  • Plasmid DNA
  • Cell Therapies
  • Other Services
    • Aseptic Fill & Finish
    • QC Services
    • Conjugated Biotherapeutics

Company

  • About us
  • Contact
  • Careers

Legal

  • Privacy Policy
  • Cookies Policy
  • Whistleblower Policy
  • Legal Notice
  • LinkedIn
3PBIOVIAN

© 3PBIOVIAN 2024